| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | PD-0325901 | gCSI | pan-cancer | AAC | -0.041 | 0.5 |
| mRNA | XL765 | CTRPv2 | pan-cancer | AAC | 0.031 | 0.5 |
| mRNA | BRD-K51490254 | CTRPv2 | pan-cancer | AAC | 0.03 | 0.5 |
| mRNA | Erlotinib | UHNBreast | pan-cancer | AAC | -0.21 | 0.5 |
| mRNA | SNS-032 | CTRPv2 | pan-cancer | AAC | 0.029 | 0.5 |
| mRNA | AZD6244 | UHNBreast | pan-cancer | AAC | -0.22 | 0.5 |
| mRNA | LRRK2-IN-1 | CTRPv2 | pan-cancer | AAC | 0.03 | 0.5 |
| mRNA | crizotinib:PLX-4032 (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.028 | 0.5 |
| mRNA | Crizotinib | gCSI | pan-cancer | AAC | 0.045 | 0.5 |
| mRNA | TAE684 | CCLE | pan-cancer | AAC | -0.036 | 0.5 |